Search research articles
Contact Us
Filters
Showing results (41-50 of 247) with videos related to
Page
of 25
Sort By:
Oncotarget
|
September 1, 2018
A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors
Jordi Rodon, Giuseppe Curigliano, Jean-Pierre Delord, et al.
The Oncologist
|
August 22, 2014
Phase I study of sunitinib in combination with gemcitabine and capecitabine for first-line treatment of metastatic or unresectable renal cell carcinoma
Joaquim Bellmunt, Cristina Suarez, Enrique Gallardo, et al.
Oncology Letters
|
July 3, 2015
Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate
Juan Sepulveda-Sanchez, Ana Ramos, Amaya Hilario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2015
Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma
Jennifer R Brown, Matthew S Davids, Jordi Rodon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2016
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies
Khaldoun Almhanna, Thea Kalebic, Cristina Cruz, et al.
JCO Precision Oncology
|
April 5, 2024
First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report
Camilla O Hoff, Eduardo Andreazza Dal Lago, Juliana Mota Siqueira, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2014
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma
Devalingam Mahalingam, Laeeq Malik, Muralidhar Beeram, et al.
Immunotherapy
|
September 9, 2020
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
José María Díez, Carolina Romero, Júlia Vergara-Alert, et al.
Emerging Microbes & Infections
|
November 13, 2019
Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein
Jordi Rodon, Nisreen M A Okba, Nigeer Te, et al.
Drugs in Context
|
December 20, 2016
Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer
Ivelina Gueorguieva, Ann Cleverly, Durisala Desaiah, et al.
Page
of 25
Search research articles
Search
Showing results (41-50 of 247) with videos related to
Sort By:
Page
of 25
Oncotarget
|
September 1, 2018
A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors
Jordi Rodon, Giuseppe Curigliano, Jean-Pierre Delord, et al.
The Oncologist
|
August 22, 2014
Phase I study of sunitinib in combination with gemcitabine and capecitabine for first-line treatment of metastatic or unresectable renal cell carcinoma
Joaquim Bellmunt, Cristina Suarez, Enrique Gallardo, et al.
Oncology Letters
|
July 3, 2015
Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate
Juan Sepulveda-Sanchez, Ana Ramos, Amaya Hilario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2015
Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma
Jennifer R Brown, Matthew S Davids, Jordi Rodon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2016
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies
Khaldoun Almhanna, Thea Kalebic, Cristina Cruz, et al.
JCO Precision Oncology
|
April 5, 2024
First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report
Camilla O Hoff, Eduardo Andreazza Dal Lago, Juliana Mota Siqueira, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2014
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma
Devalingam Mahalingam, Laeeq Malik, Muralidhar Beeram, et al.
Immunotherapy
|
September 9, 2020
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
José María Díez, Carolina Romero, Júlia Vergara-Alert, et al.
Emerging Microbes & Infections
|
November 13, 2019
Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein
Jordi Rodon, Nisreen M A Okba, Nigeer Te, et al.
Drugs in Context
|
December 20, 2016
Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer
Ivelina Gueorguieva, Ann Cleverly, Durisala Desaiah, et al.
Page
of 25